Will testosterone treatment in combination with a lifestyle program normalise glucose tolerance in men with either pre-diabetes or newly diagnosed type 2 diabetes, in comparison to placebo and a lifestyle program?

Trial Profile

Will testosterone treatment in combination with a lifestyle program normalise glucose tolerance in men with either pre-diabetes or newly diagnosed type 2 diabetes, in comparison to placebo and a lifestyle program?

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 24 May 2017

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Glucose intolerance; Hypogonadism; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms T4DM
  • Most Recent Events

    • 21 Apr 2017 Planned End Date changed from 31 Dec 2016 to 7 May 2019.
    • 21 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 Jul 2012 Planned initiation date changed from 1 Jul 2012 to 1 Sep 2012 as reported by Australian New Zealand Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top